Abstract: Following ligand stimulation, several Toll-like receptors (TLRs) are phosphorylated at tyrosine residues in their intracellular domains. However, the precise chain of events leading to tyrosine-phosphorylation-dependent TLR-mediated cytokine secretion has not been defined. We focused on elaborating the signaling pathway of tyrosine-phosphorylated TLR2. We demonstrated that two tyrosine residues in the intracellular domain of TLR2, Y616 and Y761, were important for cytokine secretion. We also showed that the src-kinase, Fyn, is constitutively associated with TLR2. TLR2-ligand stimulation increases the amount of phosphorylated Fyn and phosphorylated TLR2. The p85-PI3K complex together with PKC associated with TLR2 in a src-kinase dependent manner. We identified crosstalk between this complex and two components of the TLR2 tyrosine-phosphorylation-independent pathway, IRAK-1 and TRAF6. Our results demonstrate that the downstream events of ligand-stimulated TLR2, including activation of NF B and Erk1/2 as well as cytokine secretion, are src-kinase dependent.
INTRODUCTION
The innate immune system is the host's first line of defense against microbial infections and responds to pathogens by recognizing molecules unique to pathogens known as pathogen-associated molecular patterns (PAMPs). Innate immune receptors that recognize PAMPs are termed pattern-recognition receptors (PRRs). In mammals, two major families of leucine-rich repeat-containing PRRs are present on the cell surface: CD14 and Toll-like receptors (TLRs).
TLRs signal through their intracellular domain which contains a consensus Toll-IL-1 receptor (TIR) domain [1] . Different signaling complexes have been associated with TLRs depending on the phosphorylation state of tyrosines in their TIR domain. The TLR tyrosine phosphorylationindependent signaling pathway involves the association of the TIR domain with the TIR-containing adaptor molecule, MyD88, with or without the participation of TIRAP/MAL (another TIR adaptor molecule) and the sequential binding of IRAK-1/IRAK-4 and TRAF6 to the complex. This complex in turn activates TAK1, a mitogen-activated protein kinase kinase kinase (MAPKKK), which leads to the activation of both NF B translocation (via IKKs and I B ) and MAPKs (JNK and p38 via MKK4/7 and MKK3/6, respectively).
The tyrosine-phosphorylation-dependent TLR signaling complex involves the association of TLRs with the p85 subunit of PI3K, MyD88, Rac1 and Btk [2] [3] [4] . In the case of TLR2, the formation of the latter complex requires the phosphorylation of its two tyrosine residues, Y616 and Y761, which presumably bind to p85 through its SH2 *Address correspondence to this author at the University of Massachusetts Medical School, 364 Plantation St. LRB 226, Worcester, MA 01605, USA; Tel: 508-856-3531; Fax: 508-856-6176; E-mail: evelyn.kurt-jones@umassmed.edu domains. One of the downstream products of this pathway is the phosphorylation of the p65 subunit of NF B and the induction of p65 transactivation [4] [5] [6] . It is also known that TLR3 and TLR4 [7] [8] [9] are tyrosine-phosphorylated following ligand engagement. Src-family kinases have been implicated as the kinases responsible for the phosphorylation of TLR2 and TLR4 [9, 10] . The complete sequence of signaling events involved in this pathway, however, is poorly understood. In addition, the cooperation between the tyrosine phosphorylation-independent and the phosphorylationdependent pathways is unknown.
This study retraced the signaling sequence that starts with ligand stimulation of TLR2. The results demonstrated that TLR2-mediated cytokine induction involves the activation of the src-family kinase Fyn, as well as activation of IRAK/TRAF6 prior to phosphorylation of the p65 subunit of NF B. Our study of the signaling pathway of tyrosinephosphorylated TLR2 is the first to demonstrate that the two TLR signaling pathways, the well-established tyrosinephosphorylation-independent pathway (mediated thru IRAK-1 -TRAF6) and the tyrosine-phosphorylation-dependent pathway (mediated thru src -PI3K), act in concert with each other and that Fyn, together with p85, IRAK-1, TRAF6 and PKC form a unified signaling chain that transmits signals from TLR2 to downstream mediators leading to cytokine secretion.
(H. pylori) NCTC 11637 (ATCC, Manassas, VA) was provided by Dr. Jean-Marie Houghton (University of Massachusetts Medical School, Worcester, MA). IL-1 was purchased from R&D Systems; TNF was purchased from Prepro Tech; lipopolysaccharide (LPS) from E. coli serotype 0111:B4 was purchased from Sigma (St. Louis, MO) and phenol extracted as previously described [11] ; and Zymosan was also purchased from Sigma (St. Louis, MO) and preparations consisted of yeast cell walls (ghost cells) with an average particle diameter of 3 microns. Inhibitors were obtained from the following sources: PP1 from Biomol (Plymouth Meeting, PA) and PP2, PP3, and SU6656 were purchased from Calbiochem (San Diego, CA). Antibodies (Ab) used in this study were obtained from the following sources: Anti-FLAG M2 and isotype controls UPC10, MOPC195, MOPC21/31c (Sigma); anti-p85a (clone AB6, Upstate Biotechnology, Lake Placid, NY); anti-p85a (Z8), anti-PKC (H1), anti-IRAK (F4 and H273), anti-TRAF6 (H274 and D10), anti-GFP (FL and B2), anti-Fyn (15 and FYN3) and anti-c-Src (H12 and N16) (Santa Cruz Biotechnology, CA); and anti-ERK1/2 and anti-ERK1/2 pT/pY 185/187 (Invitrogen, Carlsbad, CA). ELISA kits against human IL-1 , IL-6, IL-8, MCP-1 and TNF were from BD Pharmingen (San Diego, CA).
Cells and Cell Culture
Stably-transfected cell lines expressing TLR2 or CD14 were generated as previously described [12] . Briefly, HEK293 cells were transfected with pCDNA3-hTLR2-YFP (H2.YFP) and plasmids encoding puromycin resistance (gift of Dr. Richard Kitchens, University of Texas Southwestern Medical Center), pCDNA3-hCD14 and/or pFLAG-hTLR2 (Tularik, San Francisco, CA; FLAG-epitope tagged at the Nterminus) using Escort reagent (Sigma, St. Louis, MO) according to the manufacturer's protocol. HEK293 cells (ATCC, Rockville, MD) were grown in RPMI-1640 medium (Gibco BRL, Grand Island, NY) supplemented with 10% heat-inactivated fetal bovine serum (Atlanta Biologicals, Norcross, GA). A Chinese hamster ovary (CHO) cell line transfected with CD14 and FLAG-TLR2 (CHO-3E10-TLR2) was provided by Dr. Douglas Golenbock (University of Massachusetts Medical School, Worcester, MA). CHO-3E10-TLR2 cells were maintained in HAM F-12 culture medium (BioWhittaker) supplemented with 10% heatinactivated fetal bovine serum (FBS, HyClone), 10 mM HEPES, 2 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin (BioWhittaker). Human monocytes were prepared from discarded peripheral blood cells from platelet donors as previously described [13] . Briefly, mononuclear cells were isolated by Ficoll density centrifugation. T cells and NK cells were depleted by incubating the mononuclear cells with anti-CD2 and anti-CD3 monoclonal antibodies followed by goat anti-mouse coupled magnetic beads. After removal of the T cells and NK cells with a magnet, the purity of the monocyte preparation was determined by flow cytometry with phycoerythrin-conjugated antibodies specific for CD14, CD4 and CD3. Monocyte purity was routinely >90%. Monocytes were cultured in RPMI-1640 medium supplemented with 10% heat-inactivated fetal calf serum (FCS) and 1% penicillin-streptomycin. All cell lines were cultured at 37°C in the presence of 5% CO 2 in a humidified incubator.
Transfection Studies
FLAG-hTLR2 mutants were created by QuikChange sitedirected mutagenesis kit (Stratagene, La Jolla, CA). Primers used to create pFLAG-hTLR2 (Y616A) were CCATGGCCT GTGGGCTATGAAAATGATGTGGG (forward primer) and CCCACATCATTTTCATAGCCCACAGGCCATGG (reverse primer). Primers used to create the Y761A mutation were GAACACCAAGACCGCCCTGGAGTGGCCCATGGACG AG (forward primer) and CTCGTCCATGGGCCACTCCA GGGCGGTCTTGGTGTTC (reverse primer). All transient transfections were done with the Polyfect transfection reagent (Qiagen, Valencia, CA).
Western Blotting and ELISA Analysis
Cells were stimulated with either heat-killed Listeria monocytogenes (HKLM) (10 8 /ml) or H. pylori (10 7 /ml) in Dulbecco's Modified Eagle Medium (DMEM), 10% FBS for the indicated time points (between 1-10 minutes). Cells (~3x10 6 HEK cells or ~5x10 6 peritoneal exudate cells [PECs, for pERK1/2 western]) were lysed in 1% Triton X-100, 20 mM Tris-HCl [pH 7.7] , 150 mM NaCl, 1 mM sodium vanadate, 10 mg/ml leupeptin, 0.15 U/ml aprotinin, 1 mM PMSF on ice for 30 min. and centrifuged. A Bradford Assay was performed to determine protein concentration and 200 μg of protein used for the immunoprecipitations with protein G agarose. Samples were subjected to electrophoresis through a mini-SDS-PAGE gel (7.5% or 4-15% gradient) and then transferred to a nitrocellulose membrane. The membrane was blocked with 5% BSA or 5% milk in TBSTween 20 (0.1%) for 1 hour. Following two washes with TBS-Tween 20, the membrane was incubated with various antibodies for 1 hour at room temperature or overnight at 4 o C. The membrane was washed twice in TBS-Tween 20 and incubated in the appropriate horse radish peroxidase (HRP)-conjugate secondary Ab, washed 2x and developed by ECL (GE Healthcare). If needed, immunoblots were stripped using stripping buffer (Chemicon, Temecula, CA) for 12 min. at room temperature, washed 3x in TBS-Tween 20/5% milk and re-immunoblotted. ELISA assays were performed on cells grown and stimulated in 24-well plates (~2x10 5 for CHO and HEK cells, 1x10 6 for peripheral blood mononuclear cells (PBMCs)). ELISA assays were performed at least twice with duplicates for each sample.
Immunocomplex In Vitro Kinase Assay
CHO-3E10-TLR2 cells (~3x10 6 cells) were lysed on ice for 15 min. in lysis buffer (0.5% NP40; 150 mM NaCl; 20 mM Tris [pH 7.4]; 10 mM iodoacetimide; 1 mM sodium vanadate; 10 mg/ml leupeptin, 0.15 U/ml aprotinin; and 1 mM PMSF). Insoluble debris was removed by microcentrifugation (15,000 x g) for 15 min. The lysates were incubated for 2 hrs. at 4 o C with mAb's previously bound to protein-G agarose beads (Boehringer Mannheim, Indianapolis, IN). The beads were then washed 2x in lysis buffer and once in kinase buffer (25 mM HEPES [pH 7.5], 1 mM MnCl 2 and 0.1 mM sodium vanadate). The beads were resuspended in 50 ml of kinase buffer with 20 mCi ( -32 P) ATP (New England Nuclear, Boston, MA) and incubated for 15 min. at room temperature and then washed once with lysis buffer with 10 mM EDTA and once with lysis buffer alone. Samples were either boiled in 1x reducing Laemmli sample buffer and subjected directly to SDS-PAGE analysis or eluted in elution buffer (0.5% SDS, 10 mM HEPES [pH 7.5] and 1 mM NaF) at 70 o C for 3 min. and diluted 30 fold with cold lysis buffer. The eluate was subjected to reimmunoprecipitation with various mAb's or pAb's, washed 2x in lysis buffer, boiled in 1x reducing Laemmli sample buffer and subjected to electrophoresis through a 9% SDS-PAGE gel.
RESULTS

Both the CD14 Signaling Complex and the TLR2 Signaling Complex Contain Src-Kinases But Have Observable Differences in Complex Composition
Our laboratory previously demonstrated that CD14, a coreceptor with TLR2 for a wide variety of microbial ligands, is constitutively associated with src-kinases [13] . Therefore, we began by investigating the possibility that the activation of the TLR2 signaling complex is due to its association with CD14 and CD14-associated src-kinases. To address this, the kinase activities of the TLR2-associated signaling complex and the CD14-associated signaling complex were compared using the immunocomplex in vitro kinase method to label TLR2-and CD14-associated phosphoproteins. PP1 and PP2 inhibited the src-family kinase-mediated 32 P-labeling of the TLR2-and CD14-associated phosphoproteins. Both the TLR2 and the CD14 complexes contained src-kinase bands at ~60kD and the activations of both complexes were sensitive to src-kinase inhibitors (Fig. 1) . However, TLR2 was associated with a signaling complex that differed from that of CD14 in some important aspects, notably an unidentified band at ~90-95kD that was not found in the CD14 complex (Fig. 1) . We focused on the TLR2 signaling pathway to further examine the events of the tyrosinephosphorylation-dependent TLR signaling pathway. 
Two Conserved Tyrosine Residues in TLR2 are Required for Phosphorylation-Dependent TLR2 Signaling
Two highly conserved tyrosine residues in the intracellular domain of TLR2, Y616 and Y761, have been implicated in phosphorylation-dependent TLR2 signaling [4] . To investigate the role of Y616 and Y761, HEK cells expressing CD14 (but not TLR2) were transiently transfected with TLR2 wild-type; TLR2 Y616A , TLR2 Y761A single mutants; or the TLR2 Y616A, Y761A double mutant. The level of expression of WT-TLR2 and the TLR2 mutants was comparable (data not shown). Transfected cells were then stimulated with the TLR2/6 ligand Pam2 and the TLR2/1 ligand Pam3 and the production of the cytokine IL-8 was measured. Both the TLR2 Y761A mutant and the double mutant greatly reduced IL-8 production while the TLR2 Y616A mutant either enhanced IL-8 production (in the case of Pam2 stimulation) or had no effect (Pam3 stimulation) ( Fig. 2A) . . After 24 hr, the cells were stimulated overnight with the following: H. pylori (10 7 /ml), araLAM (LAM, 1μg/ml), peptidoglycan (PGN, 10μg/ml), zymosan (10μg/ml) or TNF (negative control, 100ng/ml). The supernatants were analyzed for IL-8 using an ELISA. Data shown are representative of two independent experiments each with duplicates for each sample, and are reported as means and SD for replicates. Using a panel of TLR2 ligands (Fig. 2B) we showed that the TLR2 Y616A, Y761A double mutant had a significantly reduced ability to stimulate IL-8 secretion with all of the ligands tested while the TLR2 Y616A single mutant showed a significant reduction in IL-8 secretion when stimulated by araLAM (a TLR2/1 ligand). Both TLR2/1 and TLR2/6 ligands required both tyrosine residues, demonstrating that the main signaling pathway originates from TLR2. Thus, both tyrosine residues 616 and 761 of TLR2 are important for TLR2 signaling.
TLR2 is Constitutively Associated with the Src-Kinase Fyn
The two conserved tyrosine residues in TLR2 could be required for binding to signaling molecules such as srckinases. To explore the role of src-proteins in TLR2 signaling, we examined if TLR2 physically associates with Fyn, a widely-expressed, membrane-bound src-kinase. The association of Fyn with TLR2 was probed by coimmunoprecipitation -western blotting in TLR2-HEK cells transfected with Fyn. The results demonstrated that TLR2 is constitutively associated with Fyn (Fig. 3A) .
TLR2 is tyrosine-phosphorylated following ligand stimulation [4, 10] . Therefore, we asked if the association of src kinases with TLR2 was affected by the phosphorylation state of TLR2. TLR2-HEK cells were ligand-stimulated, srckinases immunoprecipitated, and tyrosine-phosphorylated proteins were co-immunoprecipitated with src-kinases and visualized by western blotting. As shown in Fig. (3B) , a ~90kD phosphoprotein co-immunoprecipitated with srckinases following ligand stimulation. Stripping and reprobing of the blot revealed that this tyrosine-phosphorylated band was TLR2 (Fig. 3B, middle panel) . The appearance of TLR2 as a doublet indicated that two different phosphorylation states were present in the src-kinase-associated TLR2 molecules. Both bands were visualized by anti-phosphotyrosine antibodies, and likely represent mono-and diphosphorylated forms of TLR2. This is consistent with the fact that there are two putative tyrosine phosphorylation sites in TLR2 (it is likely that the PAGE experiment was unable to separate the two different forms of mono-phosphorylated TLR2). Following ligand-stimulation with peptidoglycan (PGN) the level of tyrosine-phosphorylation of src-kinase bound TLR2 increased (Fig. 3B, upper panel) while the amount of TLR2 that was associated with src-kinases changed only slightly (Fig. 3B, middle panel) . The amount of src-kinases stayed constant (Fig. 3B, lower panel) .
Src-family kinases are activated by their associations with tyrosine-phosphorylated receptor proteins and the subsequent phosphorylation of a conserved tyrosine residue within their activation loops [14] . Thus, the question of whether Fyn is phosphorylated following TLR2 ligand stimulation was investigated. HEK293 cells expressing FLAG-TLR2 and CD14 (TLR2-HEK) were stimulated with PGN and the tyrosine phosphorylation of Fyn investigated by immunoprecipitation -western blotting. As shown in Fig. (3C, upper panel) Fyn was rapidly tyrosinephosphorylated at Tyr59 following TLR2 activation while the amount of Fyn stayed constant (lower panel).
Ligand-Dependent Formation of the TLR2 -Fyn -p85 Complex
An important interaction of ligand-stimulated TLR2 is the association of TLR2 with the p85 subunit of PI3K [4] . Tyrosine kinases are required to phosphorylate the tyrosines in the TLR2 intracellular domain in order for them to associate with the p85 SH2 domain(s). We hypothesized that src-kinases are required for this phosphorylation event. To investigate this, TLR2-HEK cells were stimulated with heatkilled Listeria monocytogenes (HKLM) with or without preincubation with the src-kinase inhibitor PP1, and the association of TLR2 and p85 detected by coimmunoprecipitation -western blotting. Notably, stimulation with whole bacteria was necessary to provide the robust response required to see the interaction. The results demonstrated that the ligand-activated association of TLR2 (Fig. 4A ) [4] . Pre-incubation of the cells with PP1 abolished this association.
Since TLR2 associates with the src-kinase Fyn and p85, the ligand-dependence of the association of Fyn with p85 was further investigated. TLR2-HEK cells were stimulated with Helicobacter pylori (H.pylori, a TLR2 ligand). Our laboratory has previously demonstrated that H.pylori stimulates macrophages in a TLR2-dependent manner and stimulates TLR2-HEK cells but does not stimulate untransfected HEK cells [15] ). The association of Fyn with p85 was detected by co-immunoprecipitation -western blotting. As shown in Fig. (4B) , ligand stimulation increased the amount of p85 associated with Fyn. We found that stimulation with H.pylori gave a much stronger signal than heat-killed Listeria monocytogenes so we used this stimulus in subsequent experiments.
Novel Interactions with the TLR2-src-p85 Pathway
The TLR2-src-p85 pathway leads to the transactivation of p65-NF B(4). PKC , a protein which associates with TLR2 [16] and is activated by PI3-kinase, effects p65 transactivation [17] . Thus, we investigated the TLR2-stimulated association of p85 with PKC using coimmunoprecipitation -western blotting. As shown in Fig. (5A) , TLR2-ligand activation stimulated the association of p85 with PKC , indicating that PKC is involved in the TLR2-p85 pathway. This novel result established that TLR2, p85 and PKC lie on the same signaling pathway.
We next examined the crosstalk between the TLR2 tyrosine-phosphorylation-dependent pathway (TLR2 cSrc/Fyn p85 PKC ) and the TLR2 tyrosinephosphorylation-independent pathway (TLR2 MyD88 IRAK-1/IRAK-4 TRAF6) by examining the interactions between components of both pathways. IRAK-1 is required for the LPS-induced activation of PI3-kinase [17] , LPS also induces the association of p85 with MyD88, the adaptor molecule upstream of IRAK-1 [2] . Therefore the involvement of IRAK-1 in the signaling of TLR2 to PKC was investigated. TLR2-HEK cells were stimulated with H. pylori and the PKC associated with IRAK-1 was detected by co-immunoprecipitation -western blotting. As shown in Studies have shown that c-Src associates with TRAF6 in an overexpression system and also following IL-1 activation [18, 19] . Therefore, the TLR2-stimulated association of cSrc and TRAF6 was investigated. TLR2-HEK cells were ligand-stimulated, TRAF6 was immunoprecipitated and the associated c-Src detected by western blotting. As shown in Fig. (5C) , TLR2 ligand activation induced the association of TRAF6 with c-Src. (A similar result has been reported by another group [20] ).
Src Kinases are Required for TLR2 Activation of Downstream Signaling Events
TLR2 is known to activate mitogen-activated protein kinase ERK1/2, a critical component of the acute stress response, however, this pathway is poorly understood. We investigated the involvement of src-kinases in TLR2-mediated ERK1/2 activation. Murine peritoneal exudate cells (PEC) were pre-incubated with SU6656 [21] , a specific srckinase inhibitor, and stimulated with Pam2, a TLR2 ligand. The lysates were analyzed by western blotting with antiphospho-ERK1/2 and anti-ERK1/2 antibodies to detect the phosphorylation state of ERK. As shown in Fig. (6A) , Pam2 stimulation activated the phosphorylation of ERK1/2 while SU6656 pre-incubation greatly diminished activation. Furthermore, both Pam2-stimulated and Pam3-stimulated production of the cytokine MCP-1 was reduced in the presence of the src-kinase inhibitors PP2 and SU6656 (Fig. 6B) .
Another downstream pathway activated by stimulation of TIR-containing receptors, like TLR2, is the NF B pathway. It is thought that TLRs activate NF B translocation via the tyrosine-phosphorylation-independent signaling complex (MyD88, IRAK-1/IRAK-4 and TRAF6) and that the tyrosine-phosphorylation-dependent signaling complex (p85-PKC ) activates NF B transcriptional activation via p65 phosphorylation and transactivation. We investigated the role of src-kinases on the TLR2-stimulated, NF Bdependent transcription using a reporter cell line (CHO-3E10-TLR2) that expresses CD14, TLR2 and an NF Bdriven CD25-reporter gene. Upon NF B activation, CD25 is expressed on the cell surface, which can be detected by flow cytometry. The reporter cells were stimulated with the TLR2-ligand (araLAM) with or without the src-kinase inhibitor (PP2). Incubation with PP2 abrogated the induction of CD25 (Fig. 6C) . In addition, we investigated the effect on cytokine production in araLAM stimulated PBMCs with or without increasing concentrations of the src-kinase inhibitor PP1. The results revealed that IL-6 and MIP-1 levels were greatly reduced in the presence of the src-kinase inhibitor (Fig. 6D) .
Using a panel of stimulants (LPS, araLAM, PGN, and zymosan) and two different src-kinase inhibitors (PP1 and PP2) in PBMCs, we further confirmed that inhibiting srckinases reduced the levels of three cytokines, IL-6, IL-8, and MIP-1 (Appendix Fig. A1 ).
DISCUSSION
Two major pattern recognition receptors, the TLRs and CD14, are responsible for mediating the host immune response. Previous studies have shown that CD14 associated with both TLR2 and src-kinases [13, 22] . A novel finding of the current study was that the signaling complexes of TLR2 and CD14 (despite containing src-family kinases as common components) have noticeable differences. To elucidate the TLR signaling pathway, our study focused on TLR2 and its tyrosine phosphorylation-dependent signaling events. This study confirmed that src-family kinases are the major tyrosine kinases responsible for TLR2 phosphorylation to initiate the tyrosine phosphorylation-dependent signaling pathway (Fig. 7) .
TLR2-and TLR4-ligands activate src-kinases. TLR2 was previously shown to directly associate with the src-kinase, cSrc [20] ; our results demonstrate that another src-kinase, Fyn, is constitutively associated with TLR2 and that Fyn is phosphorylated following stimulation with a TLR2-ligand. We also demonstrate that Fyn is associated with two different forms of tyrosine-phosphorylated TLR2 and that TLR2-stimulation is necessary for the association of Fyn with p85. These findings, together with previous reports, establish that src kinases, c-Src and Fyn, contribute to the TLR2 tyrosine-phosphorylation-dependent pathway. Our observation that c-Src associates with TRAF6 following TLR2 activation, suggests that TRAF6 is also a downstream target of src-kinases, and is analogous to the recent finding that IL-1, which utilizes the same TIR-mediated pathway as that of TLR ligands, induces the formation of the c-Src-TRAF6 complex which in turn activates downstream signaling molecules via PI3-kinase and its target, Akt (18) .
TLRs signal to downstream effectors such as NF B by several different pathways. In particular, TLR2 leads to NF B mediated transcription via two mechanisms: NF B translocation and NF B transactivation. The first pathway involves only serine-threonine phosphorylation events and is tyrosine phosphorylation-independent. This pathway signals through the sequence TLR2 MyD88 IRAK-4/IRAK-1 TRAF6 TAK1 IKK / I B degradation NF B translocation (Fig. 7) . The second pathway, in contrast, involves at least one tyrosine phosphorylation event and signals through the sequence TLR2-pY p85-PI3K PKC p65 phosphorylation NF B transactivation (Fig. 7) . This study elaborated the crosstalk of these two pathways. In particular, this is the first study to discover the stimulation-dependent interaction between IRAK-1 and PKC . The experimental results could indicate that following TLR2 phosphorylation, Fyn, IRAK-1/TRAF6, p85-PI3K and PKC form a complex that signals downstream events (Fig. 7) .
In addition, our results suggest interactions between the signaling pathway of phosphorylated TLR2 and the downstream signaling pathway of Dectin-1 (the receptor for zymosan). The double mutant (TLR2 Y616A, Y761A ) was unable to mount a cytokine response to zymosan, suggesting that phosphorylated TLR2 works together with Dectin-1 to produce the cytokine response induced by zymosan. Dectin-1 can be phosphorylated at two tyrosine residues located in its tail sequence. Phosphorylated Dectin-1 recruits the Syk kinase, which is essential for production of the cytokines IL-2 and IL-10 in DCs [23] . It is possible that Syk kinases also play a role in phosphorylated TLR2 signaling. Because a major role for Dectin-1 is to signal downstream events leading to phagocytosis [24] it will be interesting to see if phagocytosis is affected by the TLR2 Y616A, Y761A mutations.
Our results showed that NF B-activated transcription and Erk1/2 activation as well as cytokine secretion were all srckinase dependent. Delude et al. demonstrated that NF B translocation does not require tyrosine kinase activity [25] . Our results demonstrated that TLR2 stimulation of NF Bdependent gene transcription was src-kinase dependent. The NF B-dependent transcription event requires both translocation and transactivation of its p65 subunit. The p85 pathway, which activates p65 transactivation downstream, is likely to be much more sensitive to src-kinase inhibition than the IRAK-1/TRAF6-mediated pathway, which activates NF B translocation, due to the fact that the p85 pathway involves a critical step where the phosphotyrosines of TLR2 associate with the SH2 domains of p85. The observation that src-kinase inhibition completely suppressed TLR2 association with p85 supports this hypothesis. This theory is also supported by results from the IL-1R signaling pathway, which is analogous to that of TLR2. While IL-1-activated NF B-dependent gene transcription is inhibited by PP1, the IL-1 mediated NF B translocation is unaffected [26] .
Peptidoglycans are recognized by TLR2/6, but also by a second, separate pathway effected by intracellular receptors NOD1 and NOD2 [27] . NOD1 and NOD2 activate NF B translocation via the recruitment of the serine-threonine kinase RICK/RIP2 and the polyubiquitination of RICK and NEMO/IKK , a precursor event to I B degradation. NOD1-and NOD2-recruited RICK also activates the MAPK pathways via TAK1, a MAPKKK. The TLR2-pY cSrc/Fyn p85/PI3K PKC pathway described here occurs independently of this NOD pathway. The NOD pathway is not known to be tyrosine kinase dependent and does not require the interaction of any phosphotyrosine-or SH2-containing signaling proteins such as c-Src, Fyn, p85 and PKC . We demonstrated that mutations of TLR2 tyrosines and the membrane-anchoring domain of Fyn inhibited ligand-induced cytokine responses, showing the independent significance of this pathway. While some TLR2 ligands such as H. pylori can signal through the NOD pathway, previous studies in our laboratory demonstrated that H. pylori responses in HEK cells were completely dependent on transfected TLR2 [15] , showing that TLR2 is critical in the initiation of signaling responses, even if NOD1/2 contributes to the downstream responses such as cytokine secretion. The interaction of TLR2 and its signaling molecules c-Src and p85 stimulated by heat-killed bacteria were clearly demonstrated. In PBMCs, responses to bacterial peptidoglycans are presumed to occur through the synergistic responses of TLR2 and NOD1/2. The finding in this paper that H. pylori bacteria and S. aureus peptidoglycan-stimulated cytokine responses were incompletely inhibited by the TLR2 tyrosine-signaling null mutant and that the PGN -and zymosan-stimulated IL-6 secretions (compared with MIP-1 ) were relatively insensitive to src-kinase inhibition did point to an additional, independent pathway in cooperation with the TLR2-mediated pathway (for some cytokines such as IL-6 and IL-8), and the NOD pathway is a possible candidate for future studies.
In conclusion, phosphorylation of two highly conserved tyrosines in the intracellular domain of TLR2 are required to initiate the phosphorylation dependent TLR2 signaling pathway. TLR2 phosphorylation could result in the formation of a TLR2-pY -src-kinase -IRAK-1/TRAF6 -p85-PI3K -PKC complex that in turn activates downstream effectors and leads to cytokine production. These results suggest the possibility of designing selective drugs to modulate specific components of the TLR-mediated response to microbial products.
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APPENDIX
